Publications
Detailed Information
Control of fluid balance guided by body composition monitoring in patients on peritoneal dialysis (COMPASS): study protocol for a randomized controlled trial
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Baek, Seon Ha | - |
dc.contributor.author | Oh, Kook-Hwan | - |
dc.contributor.author | Kim, Sejoong | - |
dc.contributor.author | Kim, Dong Ki | - |
dc.contributor.author | Joo, Kwon-Wook | - |
dc.contributor.author | Oh, Yun Kyu | - |
dc.contributor.author | Han, Byoung Geun | - |
dc.contributor.author | Chang, Jae Hyun | - |
dc.contributor.author | Chung, Wookyung | - |
dc.contributor.author | Kim, Yon Su | - |
dc.contributor.author | Na, Ki Young | - |
dc.date.accessioned | 2014-11-17T01:12:34Z | - |
dc.date.available | 2014-11-17T01:12:34Z | - |
dc.date.issued | 2014-11-06 | - |
dc.identifier.citation | Trials, 15(1) : 432 | ko_KR |
dc.identifier.uri | https://hdl.handle.net/10371/93573 | - |
dc.description.abstract | Background: The clinical benefits of bioimpedance spectroscopy (BIS)-guided fluid management in patients on hemodialysis have been widely demonstrated. However, no previous reports have evaluated the effect of regular and serial BIS-guided fluid management on the residual renal function (RRF) in patients on peritoneal dialysis (PD). Therefore, we will evaluate the clinical efficacy of BIS-guided fluid management for preserving RRF and protecting cardiovascular events in patients on PD.
Methods/design: This is a multicenter, prospective, randomized controlled trial. A total of 138 participants on PD will be enrolled and randomly assigned to receive either BIS-guided fluid management or fluid management based only on the clinical information for 1 year. The primary outcome is the change in the glomerular filtration rate (GFR) between months 0 and 12 after starting treatment. The secondary outcomes will include GFR at month 12, time to the anuric state (urine volume <100 ml/day), and fatal and nonfatal cardiovascular events during treatment. Discussion: This is the first clinical trial to investigate the effect of BIS-guided fluid management on RRF and for protecting against cardiovascular events in patients on PD. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | BioMed Central | ko_KR |
dc.subject | Fluid balance | ko_KR |
dc.subject | Bioimpedance spectroscopy | ko_KR |
dc.subject | Peritoneal dialysis | ko_KR |
dc.title | Control of fluid balance guided by body composition monitoring in patients on peritoneal dialysis (COMPASS): study protocol for a randomized controlled trial | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 백선하 | - |
dc.contributor.AlternativeAuthor | 오국환 | - |
dc.contributor.AlternativeAuthor | 김세중 | - |
dc.contributor.AlternativeAuthor | 김동기 | - |
dc.contributor.AlternativeAuthor | 주권욱 | - |
dc.contributor.AlternativeAuthor | 오윤규 | - |
dc.contributor.AlternativeAuthor | 한병근 | - |
dc.contributor.AlternativeAuthor | 장재현 | - |
dc.contributor.AlternativeAuthor | 정우경 | - |
dc.contributor.AlternativeAuthor | 김연수 | - |
dc.contributor.AlternativeAuthor | 나기영 | - |
dc.identifier.doi | 10.1186/1745-6215-15-432 | - |
dc.language.rfc3066 | en | - |
dc.description.version | Peer Reviewed | - |
dc.rights.holder | Seon Ha Baek et al.; licensee BioMed Central Ltd. | - |
dc.date.updated | 2014-11-14T16:04:08Z | - |
- Appears in Collections:
- Files in This Item:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.